Eiropas Savienība - lietuviešu - EMA (European Medicines Agency)

boehringer ingelheim vetmedica gmbh - kiaulės parvovirus, kamienas 27a, virusinių baltymų 2 - imunologiniai vaisiai suidae - kiaulės - aktyvios imunizacijos nuo kiaulaitės ir paršavedžių nuo 5 metų mėnesių apsaugoti palikuonių prieš transplacentinis infekcija, kurią sukelia kiaulių parvovirus.

Eiropas Savienība - lietuviešu - EMA (European Medicines Agency)

laboratorios hipra s.a. - gyvos praskiestos galvijų respiratory syncytial virus (brsv), kamienas lym-56 - immunologicals už bovidae, galvijai, gyvų virusinių vakcinų, galvijų respiratory syncytial virus (brsv) - galvijai - aktyvios imunizacijos galvijų, siekiant sumažinti viruso paplitimą ir kvėpavimo klinikiniai požymiai sukelia galvijų respiratory syncytial virus infekcija.

Eiropas Savienība - lietuviešu - EMA (European Medicines Agency)

dechra regulatory b.v. - mirtazapine - psychoanaleptics, antidepressants in combination with psycholeptics - katės - dėl kūno svorio padidėjimas katės patiria prastas apetitas ir svorio nuostolius, nuo lėtinių ligų.

Eiropas Savienība - lietuviešu - EMA (European Medicines Agency)

ceva-phylaxia co. ltd. - live recombinant fowlpox virus expressing the membrane fusion protein and the encapsidation protein of avian infectious laryngotracheitis virus (rfp-lt) and avian encephalomyelitis virus, strain calnek 1143 (ae) - immunologicals for aves, live viral vaccines, domestic fowl - vištiena - for active immunisation of chickens of 8 to 13 weeks of age in order to reduce the skin lesions due to fowlpox, to reduce the clinical signs and tracheal lesions due to avian infectious laryngotracheitis and to prevent egg production losses due to avian encephalomyelitis.

Eiropas Savienība - lietuviešu - EMA (European Medicines Agency)

novartis europharm limited - crizanlizumab - anemija, sirupo ląstelė - other hematological agents - adakveo is indicated for the prevention of recurrent vaso occlusive crises (vocs) in sickle cell disease patients aged 16 years and older. it can be given as an add on therapy to hydroxyurea/hydroxycarbamide (hu/hc) or as monotherapy in patients for whom hu/hc is inappropriate or inadequate.

Eiropas Savienība - lietuviešu - EMA (European Medicines Agency)

ucb pharma s.a.   - fenfluramine hydrochloride - epilepsies, myoclonic - antiepileptics, - treatment of seizures associated with dravet syndrome as an add-on therapy to other antiepileptic medicines for patients 2 years of age and older. fintepla is indicated for the treatment of seizures associated with dravet syndrome and lennox-gastaut syndrome as an add-on therapy to other anti-epileptic medicines for patients 2 years of age and older.

Eiropas Savienība - lietuviešu - EMA (European Medicines Agency)

intervet international b.v. - cell-associated live recombinant turkey herpesvirus (strain hvt/ndv/ilt) expressing the fusion protein of newcastle disease virus and the glycoproteins gd and gi of infectious laryngotracheitis virus - imunologiniai vaistai - embryonated chicken eggs; chicken - for active immunisation of one-day-old chicks or embryonated chicken eggs:to reduce mortality and clinical signs caused by newcastle disease (nd) virus,to reduce mortality, clinical signs and lesions caused by avian infectious laryngotracheitis (ilt) virus and marek’s disease (md) virus.

Eiropas Savienība - lietuviešu - EMA (European Medicines Agency)

ecuphar nv - enflicoxib - priešgaisrinės ir antireumatinės priemonės - Šunys - for the treatment of pain and inflammation associated with osteoarthritis (or degenerative joint disease) in dogs.

Eiropas Savienība - lietuviešu - EMA (European Medicines Agency)

elanco gmbh - lotilaner, milbemycin oxime - endektokidai - Šunys - for use in dogs with, or at risk from, mixed infestations/infections of ticks, fleas, gastrointestinal nematodes, heartworm and/or lungworm.

Eiropas Savienība - lietuviešu - EMA (European Medicines Agency)

ceva-phylaxia veterinary biologicals co. ltd - turkey herpes virus, strain rhvt/nd/ibd, expressing the fusion protein of newcastle disease virus and the vp2 protein of infectious bursal disease virus, live recombinant - imunologiniai vaistai - embryonated chicken eggs; chicken - for the active immunisation of one-day-old chicks or 18-day-old chicken embryonated eggs to reduce mortality, clinical signs and lesions caused by newcastle disease virus (ndv) and to reduce virus shedding; to reduce mortality, clinical signs and bursa lesions caused by very virulent infectious bursal disease virus (ibdv); to reduce mortality, clinical signs and lesions caused by classical marek’s disease virus (mdv).